OPKO Completes Sale of Sorrento Therapeutics Stake

By: Benzinga
OPKO Health, Inc. (NYSE: OPK ) has completed the sale of its stake in Sorrento Therapeutics, Inc. (NASDAQ: SRNE ), a publicly-traded, clinical-stage biopharmaceutical company focused primarily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.